Inhibition of hypertension by peripheral administration of antisense oligodeoxynucleotides

Hypertension

Volumn 28, Issue 1, 1996, Pages 147-151

  Wielbo, Donna ^a,b   Simon, Amy ^a   Phillips, M Ian ^a   Toffolo, Shawn ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

angiotensinogen; antisense; hypertension, essential

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; ANTISENSE OLIGODEOXYNUCLEOTIDE; LIPOSOME; MESSENGER RNA; OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; HORMONE SYNTHESIS; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; LIVER; MALE; MICROSCOPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RNA TRANSLATION; SPONTANEOUSLY HYPERTENSIVE RAT; TISSUE DISTRIBUTION;

EID: 0030036372     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.1.147     Document Type: Article

References (24)

1. Jeunemaitre X, Soubrier F, Kotelevtsev KV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
2. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation. 1988;77(suppl 19):1-4.
3. Phillips MI, Speakman EA, Raizada MK. Levels of angiotensin and molecular biology of the tissue renin-angiotensin system. Regul Pept. 1993;43:1-20.
4. Dzau VJ. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. Basic Res Cardiol. 1993; 88(suppl 1):1-14.
5. Viswanathan M, Stromberg C, Seltzer A, Saavedra JM. Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta. J Clin Invest. 1992;90:1707-1712.
6. Ganten D, Hermann K, Bayer C, Unger T, Lang RE. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science. 1983;221:869-871.
7. Yongue BG, Angulo JA, McEwen BS, Meyers MM. Brain and liver angiotensinogen messenger RNA in genetic hypertensive and normotensive rats. Hypertension. 1991;17:485-491.
8. Wahlstedt D, Pich EM, Koob GF, Yee F, Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science. 1993;259:528-531.
9. Wahlstedt D, Golanor E, Yamamoto S, Yee F, Ericson H, Yoo H, Inturissi CE, Reis DJ. Antisense oligonucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischemic infarctions. Nature. 1993;363:260-263.
10. Neckers L, Whitsell L, Rosolen A, Geselowitz DA. Antisense inhibition of oncogene expression. Crit Rev Oncog. 1992;3:175-231.
11. Helene CC, Toulme JJ. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta. 1990;1049:99-125.
12. Crooke ST. Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J. 1993;7:533-539.
13. 1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept. 1993;49:167-174.
14. Wielbo D, Sernia C, Phillips MI. The distribution and antihypertensive effects of phosphorothioated antisense oligodeoxynucleotides in SHR. Hypertension. 1995;25:314-319.
15. Sakai RR, He PF, Guo YF, Reilly JJ, Moga CN, Fluharty SJ. Intracerebroventricular administration of AT1 receptor antisense oligonucleotides inhibits the behavioral actions of angiotensm II. J Neurochem. 1994;62:2053-2056.
16. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A. 1993;90:8474-8478.
17. Tomita N, Morishita R, Higaki J, Kaneda Y, Mikami H, Ogihara T. Transient decrease in high blood pressure by in vivo transfer of antisense oligonucleotide against rat angiotensinogen. Hypertension. 1995;26:131-136.
18. Temsamani J, Kubert M, Tang J, Padmapriya A, Agrawal S. Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. Antisense Res Dev. 1994;4:35-42.
19. Ahktar S, Kole R, Juliano R. Stability of antisense DNA oligonucleotide analogs in cellular extracts and sera. Life Sci. 1991;49:1793-1801.
20. Rose JK, Buonocore L, Whitt MA. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques. 1991;10:520-525.
21. Lappalainen K, Urtii A, Soderling E, Jaaskelainen I, Syrjanen K, Syrjanen S. Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells. Biochim Biophys Acta. 1994;1196:201-208.
22. Ohkubo H, Kageyama R, Ujihara M, Hirose T, Inayama S, Nakanishi S. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci USA. 1983;80:2196-2200.
23. Sernia C, Shinkel TA, Thomas WG, Ho KKY, Lincoln D. Angiotensinogen secretion by single rat pituitary cells: detection by a reverse hemolytic plaque assay and cell identification by immunocytochemistry. Neuroendocrinology. 1992;55:308-316.
24. Crooke ST. Therapeutic applications of oligonucleotides. Annu Rev Pharmacol Toxicol. 1992;32:329-376.